共 76 条
- [1] Stauffer ME(2014)Prevalence of anemia in chronic kidney disease in the United States PLoS One 9 12-19
- [2] Fan T(2010)Anemia in patients with chronic kidney disease Diabetes Spectr 21 333-337
- [3] O’Mara NB(2008)Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response? CMAJ 179 473-482
- [4] Zarychanski R(2010)Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous? Curr Med Res Opin 26 108-118
- [5] Houston DS(2015)Hepcidin in chronic kidney disease: not an anaemia management tool, but promising as a cardiovascular biomarker Neth J Med 73 2090-2093
- [6] Macdougall IC(2004)Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 306 736-743
- [7] van der Weerd NC(2007)Iron Management in Nondialysis-Dependent CKD Am J Kidney Dis 49 897-906
- [8] Grooteman MPC(2008)Intravenous versus Oral Iron supplementation for the treatment of Anemia in CKD: systematic review and meta-analysis Am J Kidney Dis 52 2075-2084
- [9] Nubé MJ(2014)FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia Nephrol Dial Transplant 29 677-690
- [10] ter Wee PM(2016)Intravenous versus Oral Iron supplementation for the treatment of Anemia in CKD: an updated systematic review and meta-analysis Am J Kidney Dis 68 382-393